PATENT CLAIM ANALYSIS

Application Number: 15874987
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "278000"]

Abstract:
The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.

Claim (Index 12):
The compound of  claim 6 , or a pharmaceutically acceptable salt thereof, wherein R 2A  is R 5 ; and R 5  is selected from the group consisting of phenyl, 1H-pyrazol-1-yl-, pyridin-2-yl-, pyridin-3-yl-, and pyridin-4-yl, wherein each of the selections is substituted with 0 or 1 substituent selected from the group consisting of \u2014CN, halogen, C 1-2  alkyl, C 3-4  cycloalkyl, C 1-2  alkoxy, C 1-2  haloalkyl, and C 1-2  haloalkoxy.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 86.0
- Lexical Diversity: 1.52
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15221658', '15808242', '13215914', '14652150', '14902324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8042136651732789
- 35 USC 102 Novelty (BERT): 0.5687326789604281
- Combined Prediction Score: 0.7806655665519938
- Mean Citation Score: 367.432016
- Max Citation Score: 449.5534
- Similarity Product: 376.1172506411791

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test